Contact
Please use this form to send email to PR contact of this press release:
Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions
TO:
Kent Manson
Diasome Pharmaceuticals
+1 720-891-7644